saxagliptin
saxagliptin is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Saxagliptin. Available dosage forms: powder, tablet, film coated.
Drug details
- Generic Name
- saxagliptin
- Brand Names
- Saxagliptin
- Application Number
- ANDA205980
- Sponsor
- SK BIOTEK IRELAND LIMITED
- NDC Codes
- 3
- Dosage Forms
- POWDER, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- SAXAGLIPTIN MONOHYDRATE, SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE
Indications and Usage
1 INDICATIONS AND USAGE Saxagliptin tablets are a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1.1 ) Limitations of use: • Not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( 1.2 ) 1.1 Monotherapy and Combination Therapy Saxagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies ( 14 ) ]. 1.2 Limitation of Use Saxagliptin tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
1.1 Monotherapy and Combination Therapy Saxagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [ see Clinical Studies ( 14 ) ].